- Report
- October 2024
- 200 Pages
Global
From €3284EUR$3,750USD£2,851GBP
- Report
- August 2023
- 145 Pages
Global
From €2759EUR$3,150USD£2,395GBP
- Report
- February 2024
- 203 Pages
Global
From €4160EUR$4,750USD£3,611GBP
- Report
- April 2023
- 111 Pages
Global
From €4160EUR$4,750USD£3,611GBP
- Report
- April 2023
- 112 Pages
Global
From €4160EUR$4,750USD£3,611GBP
- Report
- December 2023
- 146 Pages
Global
From €3897EUR$4,450USD£3,383GBP
- Report
- August 2024
- 200 Pages
Global
From €4334EUR$4,949USD£3,762GBP
From €2443EUR$2,789USD£2,120GBP
- Report
- August 2024
- 250 Pages
Global
From €3897EUR$4,450USD£3,383GBP
- Report
- December 2024
- 160 Pages
Asia Pacific
From €3022EUR$3,450USD£2,623GBP
- Report
- December 2023
- 247 Pages
Global
€4375EUR$4,995USD£3,797GBP
- Report
- January 2025
- 106 Pages
Global
From €3500EUR$4,281USD£3,144GBP
The Multiplex Sequencing market is a subset of the genomics industry that focuses on the sequencing of multiple DNA samples simultaneously. This technology is used to analyze the genetic makeup of a sample, such as a tumor, to identify mutations or other genetic changes. Multiplex sequencing is also used to study the genetic diversity of a population, to identify genetic markers associated with disease, and to develop new diagnostic tests.
Multiplex sequencing is a rapidly growing field, with many companies offering products and services. These include Illumina, Thermo Fisher Scientific, Pacific Biosciences, Oxford Nanopore Technologies, 10x Genomics, and BGI Genomics. Show Less Read more
